Austin, Texas — According to state and local economic development sources Advarra plans to invest $400,000.00 to build out 9,310 square feet of new space in Austin. The company plans to occupy the new space at 3815 S. Capital of Texas Highway in Austin, on or about February 1, 2022. According to the company website Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster.

To learn more about Advarra, visit http://www.advarra.com/

Company Contact:
Gadi Saarony, Chief Executive Officer
gadi.saarony@advarra.com
https://www.linkedin.com/in/gadi-saarony-3008b11/
410-884-2900

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved